Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Methamphetamine Dependence in MSM
NCT01888835Phase 2Completed
- Start
- Aug 2013
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Number of methamphetamine-positive urine tests at 9 months. Started Aug 2013; status: completed.
02
Drugs
mirtazapine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT01888835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888835.